Table 3. The OR and 95% CI of high SYNTAX score for lung cancer in total patients and subgroup patients stratified by NLR.
Model | Total patients (n = 384) | Patients with NLR-high (n = 190*) | Patients with NLR-low (n = 190*) | ||||||||
OR | 95% CI | P-value | OR | 95% CI | P-value | OR | 95% CI | P-value | |||
*Presented as the number of patients was for those who had NLR value. Model 1: not adjusted for any variables. Model 2: adjusted for gender, age and body mass index. Model 3: adjusted for variables in model 2 plus smoking and cancer family history. Model 4: adjusted for variables in model 3 plus hypertention, diabetes mellitus and hyperlipidemia. CI: confidence interval; NLR: neutrophil-to-lymphocyte ratio; OR: odds ratio. | |||||||||||
Model 1 | 1.871 | 1.129–3.101 | 0.015 | 2.475 | 1.282–4.779 | 0.007 | 1.095 | 0.455–2.635 | 0.839 | ||
Model 2 | 1.821 | 1.074–3.090 | 0.026 | 2.694 | 1.356–5.350 | 0.005 | 0.865 | 0.340–2.199 | 0.760 | ||
Model 3 | 1.810 | 1.059–3.092 | 0.030 | 2.932 | 1.447–5.940 | 0.003 | 0.812 | 0.318–2.070 | 0.662 | ||
Model 4 | 1.834 | 1.063–3.162 | 0.029 | 2.801 | 1.355–5.794 | 0.005 | 0.897 | 0.346–2.232 | 0.823 |